Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
IPSC
#3009
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+6.42%
Variazione Mensile
-13.43%
Variazione di 6 mesi
+346.15%
Variazione Annuale
+256.92%
Chiusura Precedente
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
Volume
15
Mercati
Mercato Azionario Statunitense
Salute
IPSC
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
85.03 M
86.05 M
86.16 M
86.39 M
87.31 M
—
Valuation ratios
Enterprise value
92.81 M
28.46 M
-10.85 M
-8.61 M
-12.04 M
-3.04 M
Price to earnings ratio
-0.93
-0.63
-1.76
-2.07
-1.66
-6.12
Price to sales ratio
43.4
12.06
0.35
0.42
0.38
13.21
Price to cash flow ratio
-1.01
-0.72
-0.33
-0.4
-0.38
-1.82
Price to book ratio
0.15
0.49
0.05
0.06
0.05
0.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.08
0.1
0.24
0.11
0.14
0.6
Return on equity %
0.16
0.22
0.32
0.16
0.2
0.89
Return on invested capital %
67.18
67.16
138.89
98.45
114.82
419.32
Gross margin %
100
100
100
—
—
—
Operating margin %
4 398.1
893.67
67.95
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
3 947.66
864.65
70.13
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.39
1.5
11.7
10.72
6.25
30.16
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0.33
0
0
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.33
0.31
0.4
0.32
0.3
1.33
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.34
2.41
1.92
1.81
1.54
7.67
Net current asset value per share
2.43
2.47
1.97
1.86
1.59
7.89
Tangible book value per share
1.86
1.62
2.4
2.04
1.64
7.69
Working capital per share
2.2
0.82
1.8
1.68
1.34
5.64
Book value per share
2.31
2.05
2.79
2.43
2.04
9.32
Notizie
TD Cowen avvia la copertura su Century Therapeutics con rating Buy
TD Cowen initiates Century Therapeutics stock rating at Buy
Clear Street ribadisce il rating Buy su Century Therapeutics a $6,60
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Clear Street riduce il target di prezzo delle azioni di Century Therapeutics a $6,60
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics ottiene 135 milioni di dollari in posizionamento privato
Century Therapeutics secures $135 million in private placement
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain